Cargando…
Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
BACKGROUND: An absent dorsolateral nigral hyperintensity (DNH) is a common finding in patients with neurodegenerative parkinsonism at high or ultra‐high field susceptibility‐weighted magnetic resonance imaging (SWI). OBJECTIVE: Despite increasing use of high field magnetic resonance imaging (MRI) in...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272900/ https://www.ncbi.nlm.nih.gov/pubmed/37332641 http://dx.doi.org/10.1002/mdc3.13736 |
_version_ | 1785059601017733120 |
---|---|
author | Grossauer, Anna Müller, Christoph Hussl, Anna Krismer, Florian Schocke, Michael Gizewski, Elke Mahlknecht, Philipp Scherfler, Christoph Wenning, Gregor K. Poewe, Werner Seppi, Klaus Heim, Beatrice |
author_facet | Grossauer, Anna Müller, Christoph Hussl, Anna Krismer, Florian Schocke, Michael Gizewski, Elke Mahlknecht, Philipp Scherfler, Christoph Wenning, Gregor K. Poewe, Werner Seppi, Klaus Heim, Beatrice |
author_sort | Grossauer, Anna |
collection | PubMed |
description | BACKGROUND: An absent dorsolateral nigral hyperintensity (DNH) is a common finding in patients with neurodegenerative parkinsonism at high or ultra‐high field susceptibility‐weighted magnetic resonance imaging (SWI). OBJECTIVE: Despite increasing use of high field magnetic resonance imaging (MRI) in specialized centers, these scanners are still frequently unavailable in primary care or outpatient facilities and underdeveloped or emerging countries. Therefore, the aim of the present study was to evaluate the diagnostic utility of DNH assessment at 1.5 versus 3 T MRI to distinguish patients with neurodegenerative parkinsonism, including Parkinson's disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP), from healthy controls (HC). METHODS: Absence of DNH was assessed on visual inspection of anonymized 1.5 T and 3.0 T SWI scans in a case–control study including 86 patients with neurodegenerative parkinsonism and 33 healthy controls (HC). All study participants were consecutively recruited to undergo 1.5 and 3 T MRI. RESULTS: Overall correct classification was 81.7% (95% CI, 72.6–88.4%) for 1.5 T and 95.7% (95% CI, 89.1–98.7%) for 3 T MRI in discriminating neurodegenerative parkinsonism from controls. However, while DNH was bilaterally present in all but one of the HC at 3 T MRI, it was rated as abnormal (at least unilateral absence) in 15 of 22 HC at 1.5 T MRI, resulting in a specificity of 31.8%. CONCLUSIONS: The results of the present study demonstrate an insufficient specificity of visual assessment of DNH at 1.5 T MRI for the diagnosis of neurodegenerative parkinsonism. |
format | Online Article Text |
id | pubmed-10272900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102729002023-06-17 Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism Grossauer, Anna Müller, Christoph Hussl, Anna Krismer, Florian Schocke, Michael Gizewski, Elke Mahlknecht, Philipp Scherfler, Christoph Wenning, Gregor K. Poewe, Werner Seppi, Klaus Heim, Beatrice Mov Disord Clin Pract Research Articles BACKGROUND: An absent dorsolateral nigral hyperintensity (DNH) is a common finding in patients with neurodegenerative parkinsonism at high or ultra‐high field susceptibility‐weighted magnetic resonance imaging (SWI). OBJECTIVE: Despite increasing use of high field magnetic resonance imaging (MRI) in specialized centers, these scanners are still frequently unavailable in primary care or outpatient facilities and underdeveloped or emerging countries. Therefore, the aim of the present study was to evaluate the diagnostic utility of DNH assessment at 1.5 versus 3 T MRI to distinguish patients with neurodegenerative parkinsonism, including Parkinson's disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP), from healthy controls (HC). METHODS: Absence of DNH was assessed on visual inspection of anonymized 1.5 T and 3.0 T SWI scans in a case–control study including 86 patients with neurodegenerative parkinsonism and 33 healthy controls (HC). All study participants were consecutively recruited to undergo 1.5 and 3 T MRI. RESULTS: Overall correct classification was 81.7% (95% CI, 72.6–88.4%) for 1.5 T and 95.7% (95% CI, 89.1–98.7%) for 3 T MRI in discriminating neurodegenerative parkinsonism from controls. However, while DNH was bilaterally present in all but one of the HC at 3 T MRI, it was rated as abnormal (at least unilateral absence) in 15 of 22 HC at 1.5 T MRI, resulting in a specificity of 31.8%. CONCLUSIONS: The results of the present study demonstrate an insufficient specificity of visual assessment of DNH at 1.5 T MRI for the diagnosis of neurodegenerative parkinsonism. John Wiley & Sons, Inc. 2023-04-14 /pmc/articles/PMC10272900/ /pubmed/37332641 http://dx.doi.org/10.1002/mdc3.13736 Text en © 2023 The Authors. Movement Disorders Clinical Practice published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Grossauer, Anna Müller, Christoph Hussl, Anna Krismer, Florian Schocke, Michael Gizewski, Elke Mahlknecht, Philipp Scherfler, Christoph Wenning, Gregor K. Poewe, Werner Seppi, Klaus Heim, Beatrice Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism |
title | Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism |
title_full | Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism |
title_fullStr | Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism |
title_full_unstemmed | Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism |
title_short | Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism |
title_sort | dorsolateral nigral hyperintensity on 1.5 t versus 3 t susceptibility‐weighted magnetic resonance imaging in neurodegenerative parkinsonism |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272900/ https://www.ncbi.nlm.nih.gov/pubmed/37332641 http://dx.doi.org/10.1002/mdc3.13736 |
work_keys_str_mv | AT grossaueranna dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism AT mullerchristoph dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism AT husslanna dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism AT krismerflorian dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism AT schockemichael dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism AT gizewskielke dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism AT mahlknechtphilipp dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism AT scherflerchristoph dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism AT wenninggregork dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism AT poewewerner dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism AT seppiklaus dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism AT heimbeatrice dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism |